May 12, 2025 / 08:30PM GMT
Operator
Good afternoon, everyone. Thank you for joining OptimizeRx first-quarter fiscal 2025 earnings conference call.
With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial Officer, Ed Stelmakh; Chief Legal Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva.
At the conclusion of today's call, I will provide some important cautions regarding the forward-looking statements made by management during today's call.
The company will also be discussing certain non-GAAP financial measures, which it believes are useful in evaluating the company's operating results. A reconciliation of such non-GAAP financial measures is included in the earnings release the company issued this afternoon, as well as in the Investor Relations section of the company's website.
I would like to remind everyone that today's call is being recorded and will be made available for replay, as an audio recording of this conference call, on the Investor Relations section of the company's website.
I would now like to turn the
Q1 2025 OptimizeRx Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
